Advanced Gallbladder Risk & Metabolic Panel
The Advanced Gallbladder Risk & Metabolic Panel evaluates biomarkers related to liver and gallbladder function, pancreatic enzymes, inflammation, lipid metabolism, glucose regulation, iron stores, and vitamin D status. By combining digestive, metabolic, and cardiometabolic markers including CMP, GGT, lipase, insulin, ApoB, ferritin, and vitamin D, this panel provides a comprehensive laboratory assessment of factors that may influence gallbladder health and metabolic balance.
- $1,059.67
- $234
- Save: 77.92%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Amylase
Apolipoprotein B
Also known as: C-Reactive Protein, CReactive Protein CRP, CRP
C-REACTIVE PROTEIN
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Absolute Band Neutrophils (Only Reported If Detected)
Absolute Basophils
Absolute Blasts (Only Reported If Detected)
Absolute Eosinophils
Absolute Lymphocytes
Absolute Metamyelocytes (Only Reported If Detected)
Absolute Monocytes
Absolute Myelocytes (Only Reported If Detected)
Absolute Neutrophils
Absolute Nucleated Rbc (Only Reported If Detected)
Absolute Promyelocytes (Only Reported If Detected)
Band Neutrophils (Only Reported If Detected)
Basophils
Blasts (Only Reported If Detected)
Eosinophils
Hematocrit
Hemoglobin
Lymphocytes
MCH
MCHC
MCV
Metamyelocytes (Only Reported If Detected)
Monocytes
MPV
Myelocytes (Only Reported If Detected)
Neutrophils
Nucleated Rbc (Only Reported If Detected)
Platelet Count
Promyelocytes (Only Reported If Detected)
RDW
Reactive Lymphocytes (Only Reported If Detected)
Red Blood Cell Count
White Blood Cell Count
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
Ferritin
Also known as: Gamma Glutamyl Transferase GGT, Gamma-Glutamyl Transferase, Gamma-Glutamyl Transpeptidase, Gamma-GT, GGTP, GTP
Ggt
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
HEMOGLOBIN A1C
Also known as: Insulin (fasting)
Insulin
Also known as: LPS
Lipase
Also known as: Cholesterol, HDL,Fasting Lipids,Cholesterol, LDL, Fasting Lipids, Lipid Panel (fasting), Lipid Profile (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
Non HDL Cholesterol
Triglycerides
Also known as: ,25-Hydroxyvitamin D2, 25-Hydroxycholecalciferol (25OHD3), 25-OH-D2,D3 Vitamin, D2 Vitamin,25-Hydroxyvitamin D3,25-OH-D3, QuestAssureD 25Hydroxyvitamin D D2 D3 LCMSMS, Vitamin D, Vitamin D, 25-Hydroxy, Vitamin D2, 25-hydroxy,25-Hydroxyergocalciferol (25OHD2),Vitamin D3, 25-hydroxy
Vitamin D, 25-Oh, Total
The Advanced Gallbladder Risk & Metabolic Panel panel contains 12 tests with 69 biomarkers .
Overview of the Advanced Gallbladder Risk & Metabolic Panel
The Advanced Gallbladder Risk & Metabolic Panel is a comprehensive laboratory evaluation designed to assess biomarkers related to gallbladder function, digestive health, metabolic balance, inflammation, and cardiovascular risk. By combining multiple clinically relevant tests, this panel provides insight into several physiological systems that influence bile metabolism, fat digestion, metabolic regulation, and inflammatory activity.
The gallbladder plays an essential role in digestion by storing and releasing bile produced by the liver. Bile helps break down dietary fats and assists with the absorption of fat soluble nutrients such as vitamins A, D, E, and K. Conditions that affect bile production, lipid metabolism, or inflammatory pathways may influence gallbladder health and digestive function. Because these biological processes are closely interconnected, evaluating multiple markers together can help provide a broader picture of digestive and metabolic health.
This panel includes the Comprehensive Metabolic Panel, Gamma Glutamyl Transferase (GGT), Lipase, Amylase, Complete Blood Count with Differential and Platelets, C Reactive Protein, Lipid Panel, Hemoglobin A1c, Insulin, Apolipoprotein B, Ferritin, and Vitamin D. Together, these markers evaluate liver enzymes, bile related enzymes, pancreatic function, inflammation, blood cell health, lipid metabolism, glucose regulation, iron stores, and vitamin status.
The combination of digestive, metabolic, inflammatory, and cardiovascular markers provides a more advanced view of the biological factors that may influence gallbladder function and overall digestive physiology. For example, changes in lipid metabolism, insulin regulation, or inflammatory markers may contribute to metabolic patterns that influence bile composition and gallstone risk.
The Advanced Gallbladder Risk & Metabolic Panel is designed to support a deeper understanding of digestive health by evaluating key laboratory markers associated with hepatobiliary function, pancreatic enzymes, metabolic balance, and systemic inflammation. By integrating several categories of biomarkers into one panel, this test helps provide a comprehensive overview of physiological processes that may influence gallbladder health and metabolic wellness.
When and Why Someone Would Order This Panel
Evaluating Digestive Symptoms and Gallbladder Concerns
Healthcare providers may consider ordering the Advanced Gallbladder Risk & Metabolic Panel when evaluating digestive symptoms that could involve the liver, gallbladder, or pancreas. Symptoms such as abdominal discomfort, nausea, indigestion after fatty meals, bloating, or upper abdominal pain may prompt further laboratory evaluation to help identify potential patterns in digestive enzyme activity, liver markers, or inflammatory indicators.
Gallbladder conditions are often related to changes in bile composition, bile flow, or metabolic factors that influence cholesterol and lipid metabolism. Testing a combination of liver enzymes, pancreatic enzymes, and lipid markers can provide helpful context when investigating digestive symptoms that may involve the hepatobiliary system.
Assessing Metabolic Factors Linked to Gallbladder Health
Metabolic health plays a significant role in gallbladder physiology. Research has shown that conditions associated with metabolic imbalance such as insulin resistance, elevated cholesterol levels, or altered lipid transport may influence the composition of bile and the development of gallstones.
This panel includes markers such as Hemoglobin A1c, insulin, apolipoprotein B, and a lipid panel, which provide insight into glucose metabolism and lipid transport. Evaluating these markers together may help healthcare providers assess metabolic patterns that could be associated with gallbladder risk factors or broader cardiometabolic health.
Investigating Inflammation and Systemic Health
Inflammatory activity can influence many biological systems including digestive function and metabolic regulation. The panel includes C Reactive Protein, a widely used marker that reflects systemic inflammation. While CRP does not identify the specific source of inflammation, it can provide context when evaluating digestive symptoms or metabolic changes.
Inflammatory markers may also be considered in the broader assessment of metabolic conditions that may affect liver health, gallbladder physiology, and cardiovascular risk.
Supporting Preventive Health and Comprehensive Assessments
In addition to evaluating digestive symptoms, healthcare providers may use panels that combine metabolic and digestive markers as part of broader health assessments. Because gallbladder health is closely linked to metabolic processes involving cholesterol, insulin, and inflammation, examining these systems together may help identify trends that warrant further clinical evaluation.
Markers such as ferritin and vitamin D also provide insight into nutritional status and iron stores, which can influence systemic health and inflammatory processes.
Monitoring Changes Over Time
Healthcare providers may use laboratory panels such as this one to monitor biomarkers over time. Tracking patterns in liver enzymes, metabolic markers, inflammatory indicators, and lipid transport proteins may help provide insight into how metabolic and digestive systems are functioning across different points in time.
Repeated measurements may help support clinical monitoring, lifestyle interventions, or medical management strategies recommended by a healthcare provider.
What Does the Panel Measure
Comprehensive Metabolic Panel and GGT
The Comprehensive Metabolic Panel (CMP) evaluates multiple biochemical markers associated with liver function, kidney function, electrolyte balance, and glucose metabolism. Several markers within the CMP are particularly relevant to gallbladder and digestive health, including ALT, AST, alkaline phosphatase, and bilirubin. These markers may help provide insight into liver cell activity, bile flow, and metabolic processes involved in digestion.
The panel also includes Gamma Glutamyl Transferase (GGT), an enzyme involved in glutathione metabolism and bile transport. GGT is often used as a complementary marker to help interpret liver enzyme changes and may provide additional information related to hepatobiliary activity.
Pancreatic Enzymes
Lipase and amylase are digestive enzymes produced primarily by the pancreas. Lipase plays an important role in the breakdown of dietary fats, while amylase helps digest carbohydrates. Changes in these enzyme levels may occur when pancreatic activity or digestive enzyme production is altered.
Measuring both enzymes provides additional information about pancreatic function and digestive enzyme activity.
Complete Blood Count with Differential and Platelets
The Complete Blood Count (CBC) evaluates several components of blood health including red blood cells, white blood cells, hemoglobin, hematocrit, and platelet levels. The differential provides a breakdown of different types of white blood cells, which can offer insight into immune activity and potential inflammatory responses.
Changes in blood cell counts may help healthcare providers identify patterns associated with inflammation, infection, or physiological stress.
C Reactive Protein
C Reactive Protein (CRP) is produced by the liver in response to inflammation. Elevated CRP levels may indicate the presence of inflammatory activity in the body. Although CRP is not specific to digestive diseases, it can provide context when interpreting other markers related to metabolic health or digestive symptoms.
Lipid Panel and Apolipoprotein B
The Lipid Panel measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. These markers help evaluate lipid metabolism and cardiovascular risk patterns.
Apolipoprotein B (ApoB) provides additional insight into the number of atherogenic lipoprotein particles circulating in the bloodstream. Because cholesterol metabolism and bile composition are closely related, evaluating lipid markers alongside gallbladder related enzymes can help provide a broader metabolic perspective.
Glucose Regulation Markers
Hemoglobin A1c reflects average blood glucose levels over approximately three months and is commonly used to evaluate long term glucose regulation. Insulin levels help provide additional information about how the body regulates blood sugar and metabolic energy balance.
Together, these markers help assess patterns related to glucose metabolism and insulin sensitivity.
Ferritin and Vitamin D
Ferritin measures stored iron levels in the body and can also function as an acute phase reactant during inflammatory processes. Iron metabolism plays an important role in cellular function and systemic health.
Vitamin D is a fat soluble vitamin involved in bone health, immune regulation, and metabolic processes. Vitamin D status may also be relevant to inflammatory pathways and metabolic balance.
By combining these markers, the panel provides a multidimensional view of digestive physiology, metabolic health, inflammatory activity, and nutrient status.
How Patients and Healthcare Providers Use the Results
Interpreting Digestive and Hepatobiliary Markers
Healthcare providers may evaluate liver enzymes, GGT, and pancreatic enzymes together when assessing digestive health. Patterns in these markers can help determine whether the liver, gallbladder, or pancreas may be involved in digestive symptoms.
For example, changes in liver enzymes combined with elevated GGT may suggest hepatobiliary involvement, while increased pancreatic enzymes may indicate pancreatic enzyme activity changes. These laboratory findings may guide decisions about additional diagnostic evaluation such as imaging or specialized testing.
Assessing Gallbladder and Biliary Risk Factors
Gallbladder conditions such as gallstones are often influenced by cholesterol metabolism and bile composition. Elevated cholesterol levels, altered lipid transport, and metabolic factors such as insulin resistance may contribute to gallstone formation.
Markers including the lipid panel, apolipoprotein B, insulin, and hemoglobin A1c provide insight into metabolic patterns that may influence bile composition and gallbladder risk factors.
Healthcare providers may evaluate these markers alongside liver enzyme patterns to better understand potential metabolic contributors to gallbladder related symptoms.
Evaluating Metabolic and Cardiometabolic Health
The inclusion of metabolic markers allows healthcare providers to evaluate broader cardiometabolic patterns that may influence digestive health. Insulin regulation, lipid transport, and inflammatory markers all play roles in metabolic health and may interact with digestive physiology.
For example, metabolic conditions such as metabolic syndrome, insulin resistance, or dyslipidemia may influence both gallbladder function and cardiovascular risk. Monitoring these markers can help healthcare providers assess metabolic patterns and guide lifestyle or medical recommendations.
Monitoring Inflammatory and Nutritional Status
CRP, ferritin, and vitamin D provide additional context about systemic inflammation and nutritional status. Elevated CRP levels may reflect inflammatory activity, while ferritin levels help assess iron stores and potential inflammatory responses.
Vitamin D levels provide insight into nutrient status that may influence immune function, bone health, and metabolic regulation.
Evaluating these markers alongside digestive and metabolic indicators can help provide a broader understanding of overall physiological health.
Guiding Clinical Follow Up
Laboratory results from this panel are interpreted in the context of medical history, symptoms, and other diagnostic findings. Abnormal results may lead healthcare providers to recommend additional testing, imaging studies, dietary adjustments, or other clinical evaluations.
Because digestive symptoms and metabolic changes can have many possible causes, laboratory markers provide an important foundation for understanding biological patterns that may influence digestive and metabolic health.
A Comprehensive Laboratory Perspective on Gallbladder and Metabolic Health
The digestive system relies on the coordinated function of the liver, gallbladder, pancreas, and metabolic pathways that regulate cholesterol, glucose, and inflammatory activity. Disruptions within these interconnected systems may influence digestion, metabolic balance, and overall physiological health.
The Advanced Gallbladder Risk & Metabolic Panel brings together multiple laboratory markers that evaluate digestive enzymes, hepatobiliary function, metabolic regulation, lipid transport, inflammation, and nutrient status. By examining these systems together, the panel provides a broader understanding of the biological processes that may influence gallbladder health and metabolic wellness.
This comprehensive approach allows healthcare providers to observe patterns across several categories of biomarkers rather than evaluating individual markers in isolation. Such patterns can provide helpful insight into metabolic conditions, digestive physiology, and inflammatory activity that may affect gallbladder function and overall health.
Laboratory testing serves as an important tool in clinical evaluation and preventive health assessments. While results must always be interpreted within the context of medical history and professional clinical guidance, the information provided by this panel may support a deeper understanding of digestive and metabolic health.
By assessing a wide range of clinically relevant markers, the Advanced Gallbladder Risk & Metabolic Panel offers a comprehensive laboratory overview of physiological systems involved in digestion, metabolism, and systemic health.